Report Id: BSCM117
Global Stem Cells Market Analysis by Therapy, Application and Geography - Trends and Forecast, 2023-2028
The global stem cells market is expected to grow at an incredible CAGR of 16% from 2023 to 2028 and reach a market value of US$ 1069 Million by 2028.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HERENorth America
17
South America
11
Europe
12
APAC
15
Others
13
MARKET SNAPSHOT
Major Players
- Osiris Therapeutics Inc.
- Medipost Co Ltd
- Anterogen Co Ltd
- Pharmicell Co Ltd
- Holostem Terapie Avanzate Srl
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
25
REPORT DESCRIPTION
The global stem cells market is expected to grow at an incredible CAGR of 16% from 2023 to 2028 and reach a market value of US$ 1069 Million by 2028.
The emergence of Induced Pluripotent Stem (iPS) cells as an alternative to ESCs (embryonic stem cells), growth of developing markets, and evolution of new stem cell therapies represent promising growth opportunities for leading players in this sector.
Due to the increased funding from Government and Private sector and rising global awareness about stem cell therapies and research are the main factors which are driving this market. A surge in therapeutic research activities funded by governments across the world has immensely propelled the global stem cells market. However, the high cost of stem cell treatment and stringent government regulations against the harvesting of stem cells are expected to restrain the growth of the global stem cells market.
This report will definitely help you make well informed decisions related to the stem cell market. The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe.
Scope of the Report:
This market research report categorizes the stem cell therapy market into the following segments and sub-segments:
By Mode of Therapy
• Allogeneic Stem Cell Therapy Market
o CVS Diseases
o CNS Diseases
o GIT diseases
o Eye Diseases
o Musculoskeletal Disorders
o Metabolic Diseases
o Immune System Diseases
o Wounds and Injuries
o Others
• Autologous Stem Cell Therapy Market
o GIT Diseases
o Musculoskeletal Disorders
o CVS Diseases
o CNS Diseases
o Wounds and Injuries
o Others
By Therapeutic Applications
• Musculoskeletal Disorders
• Metabolic Diseases
• Immune System Diseases
• GIT Diseases
• Eye Diseases
• CVS Diseases
• CNS Diseases
• Wounds and Injuries
• Others
By Geography
• North America
• Europe
• Asia-Pacific
• RoW (Rest of the World)
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Stem Cell Therapy Market Overview
4.2 Regional Analysis: Market, By Type, 2018 vs 2024 (USD Million)
4.3 Global Market, By Therapeutic Application, 2018–2024 (USD Million)
4.4 Regional Analysis: Market, By Cell Source, 2018 vs 2024 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Growth Drivers
5.2.1.1 Growing Awareness Related to the Therapeutic Potency of Stem Cells in Effective Disease Management
5.2.1.2 Development of Advanced Genome-Based Cell Analysis Techniques
5.2.1.3 Increasing Public-Private Investments for the Development of Stem Cell Therapies
5.2.1.4 Development in Infrastructure Related to Stem Cell Banking and Processing
5.2.2 Market Restraints
5.2.2.1 Unclear Regulatory Guidelines for Product Development & Commercialization
5.2.2.2 Socio-Ethical Issues Related to the Use of Escs in Disease Treatment
5.2.3 Market Growth Opportunities
5.2.3.1 Supportive Regulations Across Developing Countries
5.2.3.2 Emergence of Ipscs as an Effective Alternative to Escs
5.2.4 Market Challenges
5.2.4.1 Technical Limitations Related to Production Scale-Up
5.3 Regulatory Landscape
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Rest of the World
6 Industry Insights
6.1 Introduction
6.2 Supply Chain Analysis
6.2.1 Key Stakeholders
6.2.2 Key Influencers
6.3 Pipeline Analysis
6.3.1 Pipeline Analysis: Based on Phase of Clinical Study
6.3.2 Pipeline Analysis: Based on Type
6.3.3 Pipeline Analysis: Based on the Cell Line Used
7 Global Stem Cell Therapy Market, By Type
7.1 Introduction
7.2 Allogeneic Stem Cell Therapy Market, By Application
7.2.1 Musculoskeletal Disorders
7.2.2 Wounds and Injuries
7.2.3 Surgeries
7.2.4 Acute Graft-Versus-Host Disease (AGVHD)
7.2.5 Other Applications
7.3 Autologous Stem Cell Therapy Market, By Application
7.3.1 Wounds and Injuries
7.3.2 Cardiovascular Diseases
7.3.3 Gastrointestinal Diseases
7.3.4 Other Applications
8 Global Stem Cell Therapy Market, By Therapeutic Application
8.1 Introduction
8.2 Musculoskeletal Disorders
8.3 Wounds and Injuries
8.4 Cardiovascular Diseases
8.5 Surgeries
8.6 Gastrointestinal Diseases
8.7 Other Applications
9 Global Stem Cell Therapy Market, By Cell Source
9.1 Introduction
9.2 Adipose Tissue-Derived Mesenchymal Stem Cells
9.3 Bone Marrow-Derived Mesenchymal Stem Cells
9.4 Cord Blood/Embryonic Stem Cells
9.5 Other Cell Sources
10 Stem Cell Therapy Market, By Region
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia-Pacific
10.5 Rest of the World (RoW)
11 Competitive Landscape
11.1 Overview
11.2 Market Ranking
11.3 Strategic Benchmarking
11.3.1 Product Development and Commercialization
11.4 Competitive Scenario
11.5 Recent Developments
11.5.1 Product Launches and Approvals
11.5.2 Expansions
11.5.3 Agreements, Collaborations, and Partnerships
12 Company Profiles
12.1 Introduction
12.1.1 Geographic Benchmarking
12.2 Osiris Therapeutics, Inc.
12.3 Medipost Co., Ltd.
12.4 Anterogen Co., Ltd.
12.5 Pharmicell Co., Ltd.
12.6 Holostem Terapie Avanzate Srl
12.7 JCR Pharmaceuticals Co., Ltd.
12.8 Nuvasive, Inc.
12.9 RTI Surgical, Inc.
12.10 Allosource
The stem cells market has been segmented as below:
By Therapeutic Applications
• Musculoskeletal Disorders
• Metabolic Diseases
• Immune System Diseases
• GIT Diseases
• Eye Diseases
• CVS Diseases
• CNS Diseases
• Wounds and Injuries
• Others
By Geography
• North America
• Europe
• Asia-Pacific
• RoW (Rest of the World)
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of stem cells market?
The market is expected to grow at a CAGR of 25% during the study period (2023-2028)
How big is the stem cells market value?
The stem cells market is expected to exceed more than US$ 1069 billion by 2028.
What is the segment’s covered for the stem cells market?
The segment included in the stem cells market is Mode of Therapy, Therapeutic and region.
Who are the major key vendors in the stem cells market?
Some key players operating in the stem cells market include Osiris Therapeutics, Inc, Medipost Co., Ltd Anterogen Co., Ltd, Pharmicell Co., Ltd. Holostem Terapie Avanzate Srl
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE